{
"NDC": {
"NDCCode": "51759-402-17",
"PackageDescription": "1 KIT in 1 CARTON (51759-402-17) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (51759-513-21) * .4 mL in 1 POUCH (65517-0002-1) ",
"NDC11Code": "51759-0402-17",
"ProductNDC": "51759-402",
"ProductTypeName": "HUMAN PRESCRIPTION DRUG",
"ProprietaryName": "Simlandi",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Adalimumab-ryvk",
"DosageFormName": "KIT",
"RouteName": "SUBCUTANEOUS",
"StartMarketingDate": "20240520",
"EndMarketingDate": null,
"MarketingCategoryName": "BLA",
"ApplicationNumber": "BLA761299",
"LabelerName": "Teva Pharmaceuticals USA, Inc.",
"SubstanceName": null,
"StrengthNumber": null,
"StrengthUnit": null,
"Pharm_Classes": null,
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-12-27",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20240520",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}